93 7219 (Topiramate 100 mg)
Pill with imprint 93 7219 is Yellow, Capsule-shape and has been identified as Topiramate 100 mg. It is supplied by Teva Pharmaceuticals USA.
Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizure prevention; migraine prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 7219



Topiramate
- Imprint
- 93 7219
- Strength
- 100 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
corn starch,
sodium starch glycolate type A potato,
titanium dioxide,
hypromellose 2910 (15 mPa.s),
polydextrose,
ferric oxide yellow,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00093-7219 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
68071-0813 | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "93 7219"
More about topiramate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,235)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Patient resources
- Drug Information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.